Publication:
Beta vulgaris L. var. cicla improves memory deficits in intracerebroventricular streptozotocin injected rats: Role on neuroinflammation

Simple item page
dc.contributor.authorERTAŞ, BÜŞRA
dc.contributor.authorsErtas, Busra; Topal, Fadime; Gulhan, Rezzan; Yanardag, Refiye; Sacan, Ozlem; Sener, Goksel
dc.date.accessioned2022-03-14T09:35:51Z
dc.date.available2022-03-14T09:35:51Z
dc.date.issued2021
dc.description.abstractAlzheimer's disease is a challenging disease for patients due to progressive loss of cognition and behavioral disorders. Disruption of cholinergic transmission and neuroinflammation are the most important mechanisms underlying cognitive damage. Beta vulgaris L. var. cicla (BV) has been reported to have various pharmacological effects associated with its rich antioxidant content. In addition, anti-cholinesterase and antiinflammatory activities of BV have been demonstrated in vitro. The aim of this study is to elucidate the therapeutic effect of BV against cognitive impairment, reduction in cholinergic transmission and neuroinflammation caused by intracerebroventricular (ICV) administration of streptozotocin (STZ). STZ was administered bilaterally at a dose of 3 mg/kg via ICV to rats, and BV treatment at a dose of 2 g/kg for 21 days was administered orally to STZ-induced animals. After behavioral tests, AChE activity, TNF-alpha and IL-1 beta levels were measured in hippocampus and cortex tissues excised from decapitated animals. Novel object recognition and passive avoidance test showed that the treatment of BV reverted the ICV-STZ induced memory dysfunctions in rats. Furthermore, increased AChE levels in the hippocampal and cortical tissues of STZ-induced rats were significantly reduced with 21 days of BV treatment. In conclusion, these results confirm that STZ administration caused cholinergic hypofunction, neuronal inflammation and cognitive dysfunction in rats, and BV therapy significantly inhibited these changes with its potential neuroprotective activity.
dc.identifier.doi10.29228/jrp.50
dc.identifier.issn2630-6344
dc.identifier.urihttps://hdl.handle.net/11424/243308
dc.identifier.wosWOS:000701782800007
dc.language.isoeng
dc.publisherMARMARA UNIV
dc.relation.ispartofJOURNAL OF RESEARCH IN PHARMACY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAlzheimer's disease
dc.subjectBeta vulgaris L. var. cicla
dc.subjectcholinergic dysfunction
dc.subjectneuroinflammation
dc.subjectcognitive function
dc.subjectOXIDATIVE STRESS
dc.subjectALZHEIMERS-DISEASE
dc.subjectEXTRACT
dc.subjectCHOLINESTERASE
dc.titleBeta vulgaris L. var. cicla improves memory deficits in intracerebroventricular streptozotocin injected rats: Role on neuroinflammation
dc.typearticle
dspace.entity.typePublication
local.avesis.id9a6ef85a-8ad9-4d48-a7aa-41d23a92f5b3
local.import.packageSS16
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atTRDIZIN
local.journal.numberofpages11
oaire.citation.endPage599
oaire.citation.issue5
oaire.citation.startPage589
oaire.citation.titleJOURNAL OF RESEARCH IN PHARMACY
oaire.citation.volume25
relation.isAuthorOfPublication864e7cb0-b39f-48bb-a546-ee65ffc807b2
relation.isAuthorOfPublication.latestForDiscovery864e7cb0-b39f-48bb-a546-ee65ffc807b2

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ertas et al. - 2021 - Beta vulgaris var. cicla improves memory deficits .pdf
Size:
1.4 MB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs